Delayed cyclosporine administration following simulect induction does not increase acute rejection in renal transplant recipients.

被引：0
|
作者：
Pelletier, RP [1 ]
Bumgardner, GL [1 ]
Davies, EA [1 ]
Elkhammas, EA [1 ]
Henry, ML [1 ]
Ferguson, RM [1 ]
机构：
[1] Ohio State Univ, Columbus, OH 43210 USA
来源：
TRANSPLANTATION | 2000年 / 69卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
176
引用
收藏
页码：S158 / S159
页数：2
相关论文
共 50 条
  • [1] Basiliximab (Simulect®) reduces the rate and severity of acute rejection in adult liver transplant recipients.
    Neuhaus, P
    Nashan, B
    Clavien, PA
    Kittur, D
    Salizzoni, M
    Rimola, A
    Abeywickrama, K
    Ortmann, CE
    Chodoff, L
    Hall, M
    Korn, A
    TRANSPLANTATION, 2000, 69 (08) : S118 - S118
  • [2] DELAYED ACUTE REJECTION EPISODES IN CYCLOSPORINE-TREATED RENAL-TRANSPLANT RECIPIENTS
    MERION, RM
    GREATOREX, RA
    CALNE, RY
    ANNALS OF SURGERY, 1985, 201 (04) : 444 - 446
  • [3] Comparision of simulect and thymoglobulin induction in an early steroid cessation protocol in renal transplant recipients.
    Peddi, V. Ram
    Ueda, Kimi
    Bry, William
    Bohannon, Lawrence
    Silkensen, John
    Warvarix, Vasyl
    Tsien, Isabelle
    Walsh, Brian
    Arsalane, Paul
    Katznelson, Steven
    AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 453 - 453
  • [4] A prospective, randomized, phase IV comparative, trial of Thymoglobulin® versus Simulect® for the prevention of delayed graft function and acute allograft rejection in renal transplant recipients.
    Aswad, S
    Shidban, H
    Naraghi, R
    Puhawan, M
    Sabawi, M
    Mendez, RG
    Mendez, R
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 417A - 417A
  • [5] Significance of acute rejection episodes in elderly renal transplant recipients.
    Meier-Kriesche, HU
    Fanari, P
    Wiggins, JE
    Kaplan, B
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2001, 49 (04) : S152 - S152
  • [6] Depression, medication adherence, and acute rejection in renal transplant recipients.
    Joffe, M
    Gaughan, C
    Mange, KC
    Wang, YL
    Anita, W
    Newman, M
    Israni, A
    Rosas, S
    Feldman, HI
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 400A - 400A
  • [7] Early results in the use of thymoglobulin and simulect as induction therapy in high-risk renal transplant recipients.
    Hanaway, MJ
    Knechlte, SJ
    Pirsch, JD
    Odorico, JS
    D'Alessandro, AM
    Kalayoglu, M
    Becker, YT
    Chin, LT
    Cooper, JT
    Sollinger, HW
    TRANSPLANTATION, 2000, 69 (08) : S160 - S160
  • [8] DOES CYCLOSPORINE INCREASE LIPOPROTEIN(A) CONCENTRATIONS IN RENAL-TRANSPLANT RECIPIENTS
    WEBB, AT
    REAVELEY, DA
    ODONNELL, M
    OCONNOR, B
    SEED, M
    BROWN, EA
    LANCET, 1993, 341 (8840): : 268 - 270
  • [9] Secondary cyclosporine metabolites are associated with acute renal failure in heart transplant recipients.
    Asberg, Anders
    Falck, Pal
    Geiran, Odd R.
    Fiane, Arnt E.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 179 - 179
  • [10] Simulect - Immunosuppressive to prevent acute rejection in renal transplant patients
    不详
    FORMULARY, 1998, 33 (07) : 620 - 621
12345